{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": -3.734446, "regularMarketPrice": 2.32, "exchange": "NCM", "shortName": "Eledon Pharmaceuticals, Inc.", "longName": "Eledon Pharmaceuticals, Inc.", "messageBoardId": "finmb_62494905", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "bookValue": 6.11, "fiftyDayAverage": 2.35084, "fiftyDayAverageChange": -0.030840158, "fiftyDayAverageChangePercent": -0.013118782, "twoHundredDayAverage": 2.708695, "twoHundredDayAverageChange": -0.388695, "twoHundredDayAverageChangePercent": -0.143499, "marketCap": 37797672, "forwardPE": -1.5263158, "priceToBook": 0.37970537, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "tradeable": false, "cryptoTradeable": false, "earningsTimestamp": 1683837000, "earningsTimestampStart": 1691578740, "earningsTimestampEnd": 1692014400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -5.21, "epsForward": -1.52, "epsCurrentYear": -2.06, "priceEpsCurrentYear": -1.1262136, "sharesOutstanding": 13776800, "firstTradeDateMilliseconds": 1410960600000, "priceHint": 4, "regularMarketChange": -0.09000015, "regularMarketTime": 1684180800, "regularMarketDayHigh": 2.45, "regularMarketDayRange": "2.3 - 2.45", "regularMarketDayLow": 2.3, "regularMarketVolume": 129118, "regularMarketPreviousClose": 2.41, "bid": 0.0, "ask": 0.0, "bidSize": 8, "askSize": 14, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 2.42, "averageDailyVolume3Month": 145960, "averageDailyVolume10Day": 606890, "fiftyTwoWeekLowChange": 0.64, "fiftyTwoWeekLowChangePercent": 0.3809524, "fiftyTwoWeekRange": "1.68 - 3.95", "fiftyTwoWeekHighChange": -1.6300001, "fiftyTwoWeekHighChangePercent": -0.41265824, "fiftyTwoWeekLow": 1.68, "fiftyTwoWeekHigh": 3.95, "dividendDate": 1601856000, "marketState": "PRE", "displayName": "Eledon Pharmaceuticals", "symbol": "ELDN"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "19900 MacArthur Boulevard", "address2": "Suite 550", "city": "Irvine", "state": "CA", "zip": "92612", "country": "United States", "phone": "949 238 8090", "website": "https://eledon.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes Tegoprubart, an anti-CD40L antibody with high affinity for CD40 ligand, which is in Phase 2 clinical trial for kidney transplantation, IgA nephropathy, and amyotrophic lateral sclerosis, as well as preclinical Phase for xenotransplantation. The company is also developing AT-2001, which is preclinical Phase for autoimmune indications. It has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.", "fullTimeEmployees": 17, "companyOfficers": [{"maxAge": 1, "name": "Dr. David-Alexandre C. Gros M.D., Ph.D.", "age": 50, "title": "CEO & Non Independent Director", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 807955, "fmt": "807.96k", "longFmt": "807,955"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Steven N. Perrin Ph.D.", "age": 56, "title": "Pres, Chief Scientific Officer & Non Independent Director", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": {"raw": 603898, "fmt": "603.9k", "longFmt": "603,898"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Paul Sean Little", "age": 57, "title": "CFO & Principal Accounting Officer", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": {"raw": 611713, "fmt": "611.71k", "longFmt": "611,713"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John  Herberger", "title": "VP of Technical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Bryan E. Smith J.D.", "age": 42, "title": "Gen. Counsel, Corp. Sec. & Chief Compliance Officer", "yearBorn": 1980, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Gregory J. Flesher", "age": 52, "title": "Consultant", "yearBorn": 1970, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jeffrey D. Bornstein", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. David  Hovland Ph.D.", "title": "Chief Regulatory Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}